Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

IBM floats the shopping around of Watson Health

International Business Machines Corp. is looking into dealing its AI-pioneering Watson Health unit so the parent can move more nimbly into cloud computing, the Wall Street Journal is reporting.

AI-powered voice screening for COVID earns CE mark

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

Thumbnail

Healthcare M&A drops in 2020

Healthcare mergers and acquisition activity fell 13% in 2020, reflecting a significantly subdued economy due to the Covid-19 pandemic.

Virtual patients making fans of actual physicians

An AI startup’s virtual-patient technology is good enough at teaching empathy to clinicians that it’s already in use at Cedars-Sinai Medical Center in Los Angeles, the National Health Service in Britain and the University of Texas Medical Branch in Galveston.

Philips partnering with Saudi Arabia on national healthcare AI

The government of Saudi Arabia is bringing in Royal Philips to help the country of 35 million become a global leader in healthcare AI.

The 10 most expensive drugs patients may give themselves

At a list price of $86,000 per month, Zokinvy is right now the costliest medication in the U.S. that patients can self-administer.

Vaccine distribution help on the way from Google

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

Proactive AI-based ICU patient monitoring cleared for market

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup